US Stock MarketDetailed Quotes

CPHRF Cipher Pharmaceuticals Inc

Watchlist

6.500
-0.036-0.55%

15min DelayClose May 31 16:00 ET

6.429
-0.071-1.10%

Post 16:52 ET

156.73MMarket Cap7.22P/E (TTM)

Cipher Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-47.82%2.43M

49.17%16M

77.00%2.42M

41.89%5.97M

-7.91%2.95M

138.99%4.67M

-22.36%10.73M

-76.12%1.37M

726.92%4.21M

-1.87%3.2M

Net income from continuing operations

87.47%4.92M

-23.48%20.38M

-61.10%7.66M

165.02%7.03M

42.64%3.07M

22.20%2.63M

243.34%26.64M

600.39%19.68M

234.97%2.65M

-23.57%2.15M

Operating gains losses

9,271.43%642K

-2,322.86%-778K

-696.84%-757K

502.78%434K

-697.33%-448K

58.82%-7K

-93.75%35K

-733.33%-95K

-85.74%72K

635.71%75K

Depreciation and amortization

-15.74%289K

24.06%1.23M

-19.94%273K

-20.41%269K

120.65%342K

121.29%343K

41.08%989K

124.34%341K

113.92%338K

-20.51%155K

Deferred tax

-12,933.33%-1.96M

80.87%-2.74M

109.00%1.32M

-1,865.35%-4.03M

-112.80%-16K

---15K

-12,452.63%-14.31M

-8,091.62%-14.66M

142.55%228K

490.63%125K

Other non cash items

100.00%6K

-266.67%-10K

-950.00%-17K

--2K

--3K

-93.48%6K

--2K

----

Change In working capital

-233.36%-1.7M

-7.98%-3.28M

-51.85%-6.28M

134.46%1.95M

-133.23%-214K

440.75%1.27M

-164.86%-3.03M

-242.88%-4.14M

176.85%830K

-55.92%644K

-Change in receivables

-354.37%-3.35M

1,290.28%1.71M

376.20%1.61M

-178.58%-877K

-171.70%-337K

214.75%1.32M

-105.62%-144K

-307.83%-584K

282.65%1.12M

-61.54%470K

-Change in inventory

192.64%214K

-65.34%-830K

-488.03%-454K

1,780.00%336K

-27.59%-481K

-4.05%-231K

33.77%-502K

147.37%117K

56.52%-20K

29.93%-377K

-Change in prepaid assets

-205.13%-41K

-89.00%11K

166.41%87K

-325.25%-223K

500.00%108K

-75.47%39K

-73.26%100K

-177.51%-131K

172.26%99K

-115.61%-27K

-Change in payables and accrued expense

1,151.67%1.5M

-93.16%-4.43M

-136.10%-7.76M

853.74%2.72M

-17.68%489K

-84.21%120K

-197.37%-2.3M

-215.09%-3.29M

2.43%-361K

23.24%594K

-Change in other working capital

-189.29%-25K

235.75%262K

195.58%238K

-175.00%-11K

143.75%7K

-63.16%28K

-234.97%-193K

-50.00%-249K

-104.76%-4K

-113.11%-16K

Cash from discontinued investing activities

Operating cash flow

-47.82%2.43M

49.17%16M

77.00%2.42M

41.89%5.97M

-7.91%2.95M

138.99%4.67M

-22.36%10.73M

-76.12%1.37M

726.92%4.21M

-1.87%3.2M

Investing cash flow

Cash flow from continuing investing activities

-6K

-77.78%-144K

-144K

-81K

Net PPE purchase and sale

---6K

74.07%-21K

---21K

----

--0

---81K

--0

----

Net intangibles purchase and sale

----

---123K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

---6K

-77.78%-144K

---144K

----

--0

---81K

--0

----

Financing cash flow

Cash flow from continuing financing activities

-197.06%-101K

-174.27%-5.24M

-2,528.19%-4.94M

90.72%-27K

65.28%-242K

95.38%-34K

22.59%-1.91M

76.02%-188K

71.91%-291K

-42.54%-697K

Net issuance payments of debt

-12.00%-28K

-98.21%-111K

-50.00%-36K

9.38%-29K

---21K

---25K

93.24%-56K

---24K

95.41%-32K

--0

Net common stock issuance

-144.44%-176K

-179.63%-5.56M

-2,340.67%-5.1M

53.02%-132K

66.09%-254K

90.39%-72K

-15.78%-1.99M

73.61%-209K

24.66%-281K

-68.69%-749K

Proceeds from stock option exercised by employees

63.49%103K

222.73%426K

335.56%196K

509.09%134K

-36.54%33K

384.62%63K

76.00%132K

462.50%45K

-35.29%22K

136.36%52K

Cash from discontinued financing activities

Financing cash flow

-197.06%-101K

-174.27%-5.24M

-2,528.19%-4.94M

90.72%-27K

65.28%-242K

95.38%-34K

22.59%-1.91M

76.02%-188K

71.91%-291K

-42.54%-697K

Net cash flow

Beginning cash position

38.11%39.83M

40.33%28.84M

53.17%42.09M

50.21%36.34M

52.98%33.43M

40.33%28.84M

124.76%20.55M

75.82%27.48M

50.53%24.19M

64.50%21.85M

Current changes in cash

-49.75%2.33M

21.52%10.61M

-326.76%-2.67M

54.94%5.95M

8.07%2.7M

280.84%4.63M

-23.03%8.73M

-76.14%1.18M

828.08%3.84M

-9.71%2.5M

Effect of exchange rate changes

-327.50%-171K

185.14%378K

124.18%408K

64.25%-197K

228.57%207K

-146.51%-40K

-816.13%-444K

1,500.00%182K

-755.95%-551K

-1,047.06%-161K

End cash Position

25.59%41.98M

38.11%39.83M

53.17%42.09M

50.21%36.34M

52.98%33.43M

40.33%28.84M

75.82%27.48M

50.53%24.19M

Free cash flow

-47.95%2.43M

48.96%15.86M

66.45%2.27M

44.67%5.97M

-7.91%2.95M

138.99%4.67M

-22.95%10.64M

-76.12%1.37M

711.00%4.13M

-1.87%3.2M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-47.82%2.43M	49.17%16M	77.00%2.42M	41.89%5.97M	-7.91%2.95M	138.99%4.67M	-22.36%10.73M	-76.12%1.37M	726.92%4.21M	-1.87%3.2M
Net income from continuing operations	87.47%4.92M	-23.48%20.38M	-61.10%7.66M	165.02%7.03M	42.64%3.07M	22.20%2.63M	243.34%26.64M	600.39%19.68M	234.97%2.65M	-23.57%2.15M
Operating gains losses	9,271.43%642K	-2,322.86%-778K	-696.84%-757K	502.78%434K	-697.33%-448K	58.82%-7K	-93.75%35K	-733.33%-95K	-85.74%72K	635.71%75K
Depreciation and amortization	-15.74%289K	24.06%1.23M	-19.94%273K	-20.41%269K	120.65%342K	121.29%343K	41.08%989K	124.34%341K	113.92%338K	-20.51%155K
Deferred tax	-12,933.33%-1.96M	80.87%-2.74M	109.00%1.32M	-1,865.35%-4.03M	-112.80%-16K	---15K	-12,452.63%-14.31M	-8,091.62%-14.66M	142.55%228K	490.63%125K
Other non cash items	100.00%6K	-266.67%-10K	-950.00%-17K	--2K	--2K	--3K	-93.48%6K	--2K	----	----
Change In working capital	-233.36%-1.7M	-7.98%-3.28M	-51.85%-6.28M	134.46%1.95M	-133.23%-214K	440.75%1.27M	-164.86%-3.03M	-242.88%-4.14M	176.85%830K	-55.92%644K
-Change in receivables	-354.37%-3.35M	1,290.28%1.71M	376.20%1.61M	-178.58%-877K	-171.70%-337K	214.75%1.32M	-105.62%-144K	-307.83%-584K	282.65%1.12M	-61.54%470K
-Change in inventory	192.64%214K	-65.34%-830K	-488.03%-454K	1,780.00%336K	-27.59%-481K	-4.05%-231K	33.77%-502K	147.37%117K	56.52%-20K	29.93%-377K
-Change in prepaid assets	-205.13%-41K	-89.00%11K	166.41%87K	-325.25%-223K	500.00%108K	-75.47%39K	-73.26%100K	-177.51%-131K	172.26%99K	-115.61%-27K
-Change in payables and accrued expense	1,151.67%1.5M	-93.16%-4.43M	-136.10%-7.76M	853.74%2.72M	-17.68%489K	-84.21%120K	-197.37%-2.3M	-215.09%-3.29M	2.43%-361K	23.24%594K
-Change in other working capital	-189.29%-25K	235.75%262K	195.58%238K	-175.00%-11K	143.75%7K	-63.16%28K	-234.97%-193K	-50.00%-249K	-104.76%-4K	-113.11%-16K
Cash from discontinued investing activities
Operating cash flow	-47.82%2.43M	49.17%16M	77.00%2.42M	41.89%5.97M	-7.91%2.95M	138.99%4.67M	-22.36%10.73M	-76.12%1.37M	726.92%4.21M	-1.87%3.2M
Investing cash flow
Cash flow from continuing investing activities	-6K	-77.78%-144K	-144K			0	-81K	0
Net PPE purchase and sale	---6K	74.07%-21K	---21K	----	----	--0	---81K	--0	----	----
Net intangibles purchase and sale	----	---123K	----	----	----	----	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	---6K	-77.78%-144K	---144K	----	----	--0	---81K	--0	----	----
Financing cash flow
Cash flow from continuing financing activities	-197.06%-101K	-174.27%-5.24M	-2,528.19%-4.94M	90.72%-27K	65.28%-242K	95.38%-34K	22.59%-1.91M	76.02%-188K	71.91%-291K	-42.54%-697K
Net issuance payments of debt	-12.00%-28K	-98.21%-111K	-50.00%-36K	9.38%-29K	---21K	---25K	93.24%-56K	---24K	95.41%-32K	--0
Net common stock issuance	-144.44%-176K	-179.63%-5.56M	-2,340.67%-5.1M	53.02%-132K	66.09%-254K	90.39%-72K	-15.78%-1.99M	73.61%-209K	24.66%-281K	-68.69%-749K
Proceeds from stock option exercised by employees	63.49%103K	222.73%426K	335.56%196K	509.09%134K	-36.54%33K	384.62%63K	76.00%132K	462.50%45K	-35.29%22K	136.36%52K
Cash from discontinued financing activities
Financing cash flow	-197.06%-101K	-174.27%-5.24M	-2,528.19%-4.94M	90.72%-27K	65.28%-242K	95.38%-34K	22.59%-1.91M	76.02%-188K	71.91%-291K	-42.54%-697K
Net cash flow
Beginning cash position	38.11%39.83M	40.33%28.84M	53.17%42.09M	50.21%36.34M	52.98%33.43M	40.33%28.84M	124.76%20.55M	75.82%27.48M	50.53%24.19M	64.50%21.85M
Current changes in cash	-49.75%2.33M	21.52%10.61M	-326.76%-2.67M	54.94%5.95M	8.07%2.7M	280.84%4.63M	-23.03%8.73M	-76.14%1.18M	828.08%3.84M	-9.71%2.5M
Effect of exchange rate changes	-327.50%-171K	185.14%378K	124.18%408K	64.25%-197K	228.57%207K	-146.51%-40K	-816.13%-444K	1,500.00%182K	-755.95%-551K	-1,047.06%-161K
End cash Position	25.59%41.98M	38.11%39.83M	38.11%39.83M	53.17%42.09M	50.21%36.34M	52.98%33.43M	40.33%28.84M	40.33%28.84M	75.82%27.48M	50.53%24.19M
Free cash flow	-47.95%2.43M	48.96%15.86M	66.45%2.27M	44.67%5.97M	-7.91%2.95M	138.99%4.67M	-22.95%10.64M	-76.12%1.37M	711.00%4.13M	-1.87%3.2M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall